Complement Therapeutics retweeted
𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐍𝐞𝐰𝐬: @ComplementTx received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye.
Full video: biotechtv.com/post/complemen…
Complement Therapeutics retweeted
Very pleased to present this online Tutorial around the role of the Complement System in Disease in conjunction with the Stephen J Ryan Initiative for Macular Research (RIMR) and the Doheny Eye Institute
youtu.be/AEkKDDYMcyk?si=FW7k… via @YouTube
#complement #Macula @DohenyEye
Complement Therapeutics retweeted
Great to see @ComplementTx gaining recognition for its work on the Complement Precision Medicine (CPM) platform. Patient stratification should be a major focus for clinical success. @RDUnwin #complementbiology #complementsystem #immunology
ukt.news/is-biotechs-future-…
Complement Therapeutics retweeted
A comprehensive review by @ProfClark M. Ueffing et al discusses the role of #complementbiology in #ocular disease, provides overview of #therapeutics & raises awareness on #time of intervention, proper #delivery routes & #patient selection
Worth reading!
sciencedirect.com/science/ar…
Complement Therapeutics retweeted
We've been recognised by @Labiotech_eu as one of six biotech spinouts around the world to keep an eye on! 🚀
Read more here: bit.ly/44xM6Km
#biotechnews #innovation #genetherapy #research #AMD
Complement Therapeutics retweeted
It's amazing to think this all started a few years ago with nothing more than an eppendorf and an idea. Well done on the continued expansion and march towards the clinic!
complementtx.com/complement-…
@RDUnwin @putideastowork #complementbiology
Complement Therapeutics retweeted
Gave a ‘state of the art’ talk on new strategies for treating dry AMD yesterday at the annual Austrian Ophthalmology Congress in Schladming. Great place and an amazing group of clinicians dedicated to helping patients. Thank you for the hospitality 🙏 #ophthalmology #therapy
Complement Therapeutics retweeted
Fantastic news from Complement Therapeutics. An amazing milestone, especially in the current financial environment. This will make a genuine difference to bringing novel complement modifiers closer to the clinics. Well done to all
complementtx.com/complement-…
Complement Therapeutics retweeted
The 7th #Complement UK Training Course and Symposium hosted by @ComplementUK in Cardiff was a huge success! 😁
Congrats to the amazing organising committee and the people in the white t-shirts aka Paul Morgan Lab! 😉 @Complement_BG #ComplementUK2023
Complement Therapeutics retweeted
📢 NEW: explore a Day in the Life of Harry Kwong from @ComplementTx (CTx).
Early-stage biotech company CTx's current focus is a potential gene therapy for Geographic Atrophy (late dry age-related macular degeneration).
More: lnkd.in/e_VskZtW
#AMD #WCID #biotech
Complement Therapeutics retweeted
We're #hiring!
Our team is expanding, and we're looking for leading talents to join us! We have a mix of hybrid, remote and on-site roles, so check out the links to each job in the comments.
Complement Therapeutics retweeted
📢 The first patient enrolled in our i-GAIN Natural History Study!
We will be recruiting 250 patients with geographic atrophy (#GA) secondary to age-related macular degeneration (#AMD) across the UK over the next 12 months.
Find out more here: bit.ly/3XbYmMo
Complement Therapeutics retweeted
Amazing in-depth review exploring the enigma of chromosome 10-mediated risk for AMD! All the very latest knowledge and opinions compiled into one study. Congratulations to @DocDaveAM and Marius Ueffing for leading this fascinating study 👇
sciencedirect.com/science/ar…
Complement Therapeutics retweeted
📣Join us for the 3rd in a series online #webinar for #EarlyCareerResearchers on January 25th with @ProfClark.
👉Free registration: complement.org.uk/events/
#complementsystem #careerdevelopment
Complement Therapeutics retweeted
📣 Delighted to be awarded a grant by @innovateuk Edge to collaborate with @CGTCatapult on our regulatory strategy for CTx001!
Learn more here: bit.ly/3tAbzCg
Complement Therapeutics retweeted
📢 Thrilled to announce the UK MHRA has granted CTx001, our lead investigational #GeneTherapy for #GeographicAtrophy, the Innovation Passport, a designation for innovative medicines and an entry point to the Innovative Licensing and Access Pathway (ILAP). bit.ly/3Dtx7Vw
Complement Therapeutics retweeted
Link to publication - bit.ly/3SweRR9
Complement Therapeutics retweeted
📜 Check out our co-founder, @ProfClark's latest publication on complement in age-related macular degeneration!
vimeo.com/762326215
Complement Therapeutics retweeted
Really cool, and somewhat surprising but levels of soluble complement regulators (FH & FHRs) can predict severity of COVID-19 symptoms 👇frontiersin.org/articles/10.…





















